ACCOUNTS - Final Accounts


Caseware UK (AP4) 2016.0.181 2016.0.181 2018-03-312018-03-31The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.truetrueDental practice activitesfalse2017-04-01 09457859 2017-04-01 2018-03-31 09457859 2018-03-31 09457859 2017-03-31 09457859 c:Director1 2017-04-01 2018-03-31 09457859 d:OfficeEquipment 2017-04-01 2018-03-31 09457859 d:OfficeEquipment 2018-03-31 09457859 d:OfficeEquipment 2017-03-31 09457859 d:OfficeEquipment d:OwnedOrFreeholdAssets 2017-04-01 2018-03-31 09457859 d:PatentsTrademarksLicencesConcessionsSimilar 2017-04-01 2018-03-31 09457859 d:PatentsTrademarksLicencesConcessionsSimilar 2018-03-31 09457859 d:PatentsTrademarksLicencesConcessionsSimilar 2017-03-31 09457859 d:CurrentFinancialInstruments 2018-03-31 09457859 d:CurrentFinancialInstruments 2017-03-31 09457859 d:CurrentFinancialInstruments d:WithinOneYear 2018-03-31 09457859 d:CurrentFinancialInstruments d:WithinOneYear 2017-03-31 09457859 d:ShareCapital 2018-03-31 09457859 d:ShareCapital 2017-03-31 09457859 d:RetainedEarningsAccumulatedLosses 2018-03-31 09457859 d:RetainedEarningsAccumulatedLosses 2017-03-31 09457859 c:FRS102 2017-04-01 2018-03-31 09457859 c:AuditExempt-NoAccountantsReport 2017-04-01 2018-03-31 09457859 c:FullAccounts 2017-04-01 2018-03-31 09457859 c:PrivateLimitedCompanyLtd 2017-04-01 2018-03-31 iso4217:GBP xbrli:pure

Registered number: 09457859









IMPLANTPILOT LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2018

 
IMPLANTPILOT LIMITED
REGISTERED NUMBER: 09457859

BALANCE SHEET
AS AT 31 MARCH 2018

2018
2017
Note
£
£

Fixed assets
  

Intangible assets
 4 
31,800
47,700

Tangible assets
 5 
-
66

  
31,800
47,766

Current assets
  

Stocks
  
38,583
40,210

Debtors: amounts falling due within one year
 6 
39,457
59,162

Cash at bank and in hand
  
354
1,654

  
78,394
101,026

Creditors: amounts falling due within one year
 7 
(268,530)
(263,587)

Net current liabilities
  
 
 
(190,136)
 
 
(162,561)

Total assets less current liabilities
  
(158,336)
(114,795)

  

Net liabilities
  
(158,336)
(114,795)


Capital and reserves
  

Called up share capital 
 8 
10
10

Profit and loss account
  
(158,346)
(114,805)

  
(158,336)
(114,795)


Page 1

 
IMPLANTPILOT LIMITED
REGISTERED NUMBER: 09457859
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2018

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Mr Jason Buglass
Director

Date: 19 December 2018

The notes on pages 3 to 8 form part of these financial statements.

Page 2

 
IMPLANTPILOT LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2018

1.


General information

ImplantPilot Limited, 09457859, is a private limited company, limited by shares, incorporated in England and Wales, with its registered office and principal place of business at Siren House, March Way, Battlefield Enterprise Park, Shrewsbury, Shropshire, SY3 3JE.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Going concern

The accounts have been prepared on the going concern basis on the assumption that the company will continue to be supported by the directors.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

Page 3

 
IMPLANTPILOT LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2018

2.Accounting policies (continued)

 
2.4

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
3 years straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Profit and loss account.

 
2.6

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first outbasis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.7

Debtors

Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Page 4

 
IMPLANTPILOT LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2018

2.Accounting policies (continued)

 
2.9

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

 
2.10

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.11

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in the Profit and loss account except when deferred in other comprehensive income as qualifying cash flow hedges.

 
2.12

Finance costs

Finance costs are charged to the Profit and loss account over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.13

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in the Profit and loss account when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

Page 5

 
IMPLANTPILOT LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2018

3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2017 - 0).


4.


Intangible assets




Patents

£



Cost


At 1 April 2017
79,500



At 31 March 2018

79,500



Amortisation


At 1 April 2017
31,800


Charge for the year
15,900



At 31 March 2018

47,700



Net book value



At 31 March 2018
31,800



At 31 March 2017
47,700

Page 6

 
IMPLANTPILOT LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2018

5.


Tangible fixed assets





Office equipment

£



Cost or valuation


At 1 April 2017
200



At 31 March 2018

200



Depreciation


At 1 April 2017
134


Charge for the year on owned assets
66



At 31 March 2018

200



Net book value



At 31 March 2018
-



At 31 March 2017
66

Page 7

 
IMPLANTPILOT LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2018

6.


Debtors

2018
2017
£
£


Trade debtors
22,029
47,436

Amounts owed by group undertakings
16,188
11,444

Prepayments and accrued income
1,240
282

39,457
59,162



7.


Creditors: Amounts falling due within one year

2018
2017
£
£

Trade creditors
54,239
79,200

Other taxation and social security
7,583
9,153

Other creditors
205,158
173,484

Accruals and deferred income
1,550
1,750

268,530
263,587



8.


Share capital

2018
2017
£
£
Allotted, called up and fully paid



10 (2017 - 10) Ordinary shares of £1.00 each
10
10



9.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company  to the fund and amounted to £382 (2017 - £nil) . 

 
Page 8